相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
Pierre Blanchard et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2022)
Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
Yingchen Lyu et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. Bossi et al.
ANNALS OF ONCOLOGY (2021)
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
Feng-Hua Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Screening Tools for Identifying Older Adults With Cancer Who May Benefit From a Geriatric Assessment A Systematic Review
Maja V. Garcia et al.
JAMA ONCOLOGY (2021)
Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study
Supriya G. Mohile et al.
LANCET (2021)
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
Wai Tong Ng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial
You-Ping Liu et al.
LANCET ONCOLOGY (2021)
Smoking and nasopharyngeal cancer: individual data meta-analysis of six prospective studies on 334 935 men
Jia Huang Lin et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2021)
Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer A Randomized Clinical Trial
Daneng Li et al.
JAMA ONCOLOGY (2021)
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial
Xing Lv et al.
LANCET ONCOLOGY (2021)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
Benjamin Lacas et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Anxiety and depression status prior to radiotherapy in patients with nasopharyngeal carcinoma and its effect on acute radiation toxicities
Rong Li et al.
EUROPEAN JOURNAL OF CANCER CARE (2021)
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
Yu-Pei Chen et al.
LANCET (2021)
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
Hai-Qiang Mai et al.
NATURE MEDICINE (2021)
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma A Multicenter Phase 3 Randomized Clinical Trial
Rui You et al.
JAMA ONCOLOGY (2020)
Acute Toxicities and Prognosis of Elderly Patients with Nasopharyngeal Carcinoma After Intensity-Modulated Radiotherapy: Prediction with Nomogram
Yu Liang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG
James C. H. Chow et al.
ORAL ONCOLOGY (2020)
The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era
Ya-Nan Jin et al.
CANCER RESEARCH AND TREATMENT (2019)
A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy
Lachlan J. McDowell et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Reprint of Long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total-and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy
Jingjing Miao et al.
ORAL ONCOLOGY (2019)
Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT-A study by the HKNPCSG
Wai-Tong Ng et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W. Lee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
Qi Yang et al.
EUROPEAN JOURNAL OF CANCER (2019)
Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship
James C. H. Chow et al.
RADIOTHERAPY AND ONCOLOGY (2019)
1110OPersonalized treatment according to geriatric assessment in first-line recurrent and/or metastatic (R/M) head and neck squamous cell cancer (HNSCC) patients aged 70 or over: ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials
J Guigay et al.
ANNALS OF ONCOLOGY (2019)
Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis
Yiat Horng Leong et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma
Wai-Tong Ng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy
Lachlan J. McDowell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B. Y. Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial
Lin-Quan Tang et al.
LANCET ONCOLOGY (2018)
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)
K. H. Au et al.
ORAL ONCOLOGY (2018)
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W. Lee et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma
Fangzheng Wang et al.
TRANSLATIONAL ONCOLOGY (2018)
Impact of comorbidity on tolerability and survival following curative intent intensity modulated radiotherapy in older patients with nasopharyngeal cancer
Kiattisa Sommat et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis
Ying Huang et al.
CANCER MEDICINE (2018)
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary
Supriya G. Mohile et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma
Oscar S. H. Chan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Immune checkpoint inhibitors and elderly people: A review
Amaury Daste et al.
EUROPEAN JOURNAL OF CANCER (2017)
Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma
Kiattisa Sommat et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Chiun Hsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma: Clinical and dosimetric predictors in a prospective cohort study
Rui-ping Zhai et al.
ORAL ONCOLOGY (2017)
Induction Chemotherapy plus Concurrent Chemoradiotherapy vs Concurrent Chemoradiotherapy in Elderly Patients with Advanced Nasopharyngeal Carcinoma
Chunlin Wang et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)
Concurrent chemoradiotherapy with 3-weekly versus weekly cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: A phase 3 multicentre randomised controlled trial (ChiCTR-TRC-12001979).
Hu Liang et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes
Gary D. Lewis et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Li Zhang et al.
LANCET (2016)
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun et al.
LANCET ONCOLOGY (2016)
Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review
Myung-Ju Ahn et al.
ORAL ONCOLOGY (2016)
G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
Lies Pottel et al.
BMC CANCER (2015)
Quality of life of nasopharyngeal cancer survivors in China
J. S. Hong et al.
CURRENT ONCOLOGY (2015)
Inherently poor survival of elderly patients with nasopharyngeal carcinoma
Ye Zhang et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts
Supriya Gupta Mohile et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
PO-071: ELAN Program: Personalized treatment according to geriatric assessment in elderly patients with head & neck cancer
C. Ortholan et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: Development and validation of a predictive score model
Rui Guo et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy
Tsair-Fwu Lee et al.
SCIENTIFIC REPORTS (2015)
Validity of the Age-Adjusted Charlson Comorbidity Index on Clinical Outcomes for Patients with Nasopharyngeal Cancer Post Radiation Treatment: A 5-Year Nationwide Cohort Study
Ching-Chieh Yang et al.
PLOS ONE (2015)
A Matched Cohort Study of Standard Chemo-Radiotherapy versus Radiotherapy Alone in Elderly Nasopharyngeal Carcinoma Patients
Qi Zeng et al.
PLOS ONE (2015)
Impact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: protocol for a multicentre randomised controlled trial (EGeSOR)
Lydia Brugel et al.
BMC CANCER (2014)
Multivariate analysis of prognostic factors for salvage nasopharyngectomy via the maxillary swing approach
Jimmy Yu Wai Chan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer
Hans Wildiers et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Endoscopic Surgery for Recurrent Undifferentiated Nasopharyngeal Carcinoma
Enzo Emanuelli et al.
JOURNAL OF CRANIOFACIAL SURGERY (2014)
Comparison of Comorbidity Collection Methods
Dorina Kallogjeri et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Evolution of treatment for nasopharyngeal cancer - Success and setback in the intensity-modulated radiotherapy era
Anne W. M. Lee et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Predictive factors and radiological features of radiation-induced cranial nerve palsy in patients with nasopharyngeal carcinoma following radical radiotherapy
Yiu S. Luk et al.
ORAL ONCOLOGY (2013)
Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis
Huai Liu et al.
RADIATION ONCOLOGY (2013)
Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy
Fei Han et al.
CLINICAL ONCOLOGY (2012)
Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy
Yi-Jun Hua et al.
EUROPEAN JOURNAL OF CANCER (2012)
Radical radiotherapy for nasopharyngeal carcinoma in elderly patients: The importance of co-morbidity assessment
Henry C. K. Sze et al.
ORAL ONCOLOGY (2012)
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
Gang Peng et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma
J. Ngeow et al.
ANNALS OF ONCOLOGY (2011)
Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
Qiu-Yan Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Chemotherapy-Related Hospitalization Among Community Cancer Center Patients
Michael J. Hassett et al.
ONCOLOGIST (2011)
A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma
Anne W. M. Lee et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment
Fu-Min Fang et al.
RADIOTHERAPY AND ONCOLOGY (2010)
SENSORINEURAL HEARING LOSS AFTER TREATMENT OF NASOPHARYNGEAL CARCINOMA: A LONGITUDINAL ANALYSIS
S. H. Chan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Endoscopic Nasopharyngectomy for Locally Recurrent Nasopharyngeal Carcinoma
Ming-Yuan Chen et al.
LARYNGOSCOPE (2009)
Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectabte squamous head and neck carcinoma
Sebastien Salas et al.
RADIOTHERAPY AND ONCOLOGY (2008)
Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy
Li Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Comorbidity in nasopharyngeal carcinoma: a preliminary communication on the prevalence, descriptive distribution and impact on outcome
Y. Ramakrishnan et al.
CLINICAL OTOLARYNGOLOGY (2007)
Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: Randomised, non-inferiority open trial
Imjai Chitapanarux et al.
EUROPEAN JOURNAL OF CANCER (2007)
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group
AWM Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
J Wee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer
HB Muss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial
ATC Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type
KF Foo et al.
ANNALS OF ONCOLOGY (2002)
A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer
EC Dees et al.
CANCER INVESTIGATION (2000)
分享论文
